Shah nomination advances to full Senate for consideration

"The nomination of [President Barack] Obama's pick to head USAID, Dr. Rajiv Shah, moved to the full Senate for consideration after receiving a unanimous voice vote from the Senate Foreign Relations Committee" Tuesday, Politico's Laura Rozen reports on her blog (12/8).

"[Shah's] experience working with all types of stakeholders and outcome-driven results will serve him well," Sen. Benjamin Cardin (D-Md.), a member of the committee, said, CongressDaily reports (12/9).

Foreign Policy's "The Cable" blog reports that the Senate vote on Shah could come as early as Friday. "The Cable" also looked at broader context of the ongoing reviews that are expected to affect USAID. "Shah is supposed to play a role on both the QDDR, the State Department's Quadrennial Diplomacy and Development Review, and the [National Security Council] NSC's Presidential Study Directive on Global Development, or PSD-7 for short. But although the PSD process has been slowed to allow his involvement and the QDDR is just slow, the issues they deal with are moving quickly" (Rogin, 12/8).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.